Cargando…
Moderate ischemic mitral regurgitation (IMR) and metabolic syndrome: where are we now and where are we going?
BACKGROUND: The metabolic syndrome appears to affect 10% to 25% of adult population worldwide. Several studies have described the association between metabolic syndrome and ischaemic heart disease, however, none linked metabolic syndrome to ischemic mitral regurgitation, a serious clinical problem f...
Autores principales: | Osman, Khalid A, Ahmed, Mohamed H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1660531/ https://www.ncbi.nlm.nih.gov/pubmed/17101046 http://dx.doi.org/10.1186/1475-2840-5-24 |
Ejemplares similares
-
Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
por: AHMED, MOHAMED H
Publicado: (2018) -
AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022) -
Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023) -
Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008) -
Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)